NEW YORK (GenomeWeb News) – Roche's 454 Life Sciences said this week that its Genome Sequencer FLX has been installed at the University of Barcelona in Spain. The university's Genomics Unit of the Scientific and Technical Services will use the platform to study aquaculture and DNA alterations related to human diseases.


Waters said that the National Cancer Institute's Center for Cancer Research has purchased an Acquity UPLC/Synapt HDMS system and an Acquity UPLC/Xevo TQ MS system for use in its metabolomics research programs.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.